{
    "2019-05-15": [
        [
            {
                "time": "2019-05-15",
                "original_text": "Health Care Sector Update for 05/15/2019: ABBV,ACB,ACB.TO,ECOR,IMGN",
                "features": {
                    "keywords": [
                        "Health Care",
                        "Sector Update",
                        "ABBV"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-05-15",
                "original_text": "AbbVie Announces US FDA Approval of VENCLEXTAÂ® (venetoclax) as a Chemotherapy-Free Combination Regimen for Previously Untreated Chronic Lymphocytic Leukemia Patients",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "FDA Approval",
                        "VENCLEXTA",
                        "Chronic Lymphocytic Leukemia"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-05-15",
                "original_text": "3 Reasons Why AbbVie (ABBV) Is a Great Growth Stock",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Growth Stock"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-05-15",
                "original_text": "Why AbbVie (ABBV) is a Great Dividend Stock Right Now",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Dividend Stock"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-05-15",
                "original_text": "AbbVie Settles Humira Litigation With Boehringer Ingelheim",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Humira",
                        "Litigation",
                        "Boehringer Ingelheim"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-05-15",
                "original_text": "PRESS DIGEST -Wall Street Journal - May 15",
                "features": {
                    "keywords": [
                        "Press Digest",
                        "Wall Street Journal"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}